8-K: Cyabra Debuts on Nasdaq Amidst SPAC Merger & Financial Challenges

Cyabra, Inc. completed its business combination with Trailblazer Merger Corporation I, listing its common stock on Nasdaq under CYAB, despite reporting increased operating losses and a going concern warning.

Summary

• Cyabra, Inc. (formerly Trailblazer Holdings, Inc.) completed its business combination with Trailblazer Merger Corporation I, with its common stock now trading on Nasdaq under the symbol CYAB.
• The aggregate merger consideration for Cyabra Strategy Ltd. shareholders was $106 million, with potential for up to 3 million additional common stock shares (earnout shares) based on future stock price performance ($15, $20, $25 VWAP targets).
• The company issued 3,061 shares of Holdings Series A Convertible Preferred Stock, 13,330 shares of Holdings Series B Convertible Preferred Stock, and 10,660 shares of Holdings Series C Convertible Preferred Stock.
• A PIPE (Private Investment in Public Equity) investment closed concurrently, raising $8 million through the issuance of 8,000 shares of Holdings Series B Preferred Stock and warrants to purchase 400,000 shares of Common Stock.
• Various promissory notes, including those from Alpha Capital Anstalt, were either repaid, converted into preferred stock, or assigned to Holdings as part of the transaction.
• Cyabra's revenues for the year ended December 31, 2025, increased by 37% to $5.7 million, compared to $4.2 million in 2024.
• Gross profit increased by 44% to $4.8 million in 2025, up from $3.4 million in 2024.
• Operating loss increased by 30% to $12.0 million in 2025, compared to $9.2 million in 2024.
• Net loss for 2025 decreased by 18% to $12.8 million, from $15.6 million in 2024, primarily due to a significant decrease in finance expenses.
• Annualized Recurring Revenue (ARR) remained flat at approximately $6.1 million as of December 31, 2025, similar to 2024.
• The company reported a cash and cash equivalents balance of $0.3 million as of December 31, 2025, and net cash used in operating activities of $8.1 million for the year.
• Management has identified substantial doubt about the company's ability to continue as a going concern without further funding.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with caution. While the successful Nasdaq listing and revenue growth are positive, the significant increase in operating loss, flat ARR, substantial cash burn, and explicit 'going concern' warning indicate fundamental operational and liquidity challenges that outweigh the positive aspects.

Positives

• Revenues increased by 37% to $5.7 million in 2025, demonstrating strong top-line growth.
• Gross profit improved by 44% to $4.8 million in 2025, indicating better cost efficiencies in revenue generation.
• Net loss decreased by 18% to $12.8 million in 2025, primarily driven by a significant reduction in finance expenses.
• Successful completion of the business combination and public listing on Nasdaq under the ticker symbol CYAB provides access to public capital markets.
• Key employees received 400,000 fully vested restricted stock units (RSUs) and a one-time transaction bonus of $400,000 each, aligning incentives with company performance.

Negatives

• Operating loss increased by 30% to $12.0 million in 2025, indicating worsening operational efficiency despite revenue growth.
• Annualized Recurring Revenue (ARR) remained flat at $6.1 million, suggesting challenges in securing new long-term contracts or retaining existing high-value ones.
• Net cash used in operating activities increased significantly to $8.1 million in 2025, highlighting substantial cash burn.
• The company's cash and cash equivalents balance was low at $0.3 million as of December 31, 2025.
• Management has determined there is substantial doubt about the company's ability to continue as a going concern without raising additional capital.

Risks

• Uncertainties regarding demand and market acceptance of Cyabra's products.
• Effects of technological changes and competition in the market for disinformation detection.
• Challenges in managing growth and the impact of planned expansion on future results.
• Risk of losing key personnel.
• Volatility in the price of the common stock due to various market and company-specific factors.
• Limited liquidity and trading of Cyabra's securities, potentially affecting investors' ability to sell shares.
• Management team has minimal experience managing a public company, which could impact regulatory compliance and investor relations.
• Potential for securities litigation or stockholder activism, leading to significant expenses and diversion of management resources.
• Reliance on emerging growth company and smaller reporting company exemptions may make the common stock less attractive to some investors.
• Failure to maintain proper and effective internal controls over financial reporting could impair the ability to produce accurate and timely financial statements.
• Future resales of common stock by existing stockholders after lock-up expirations could cause the market price to decline significantly.
• The company's holding company structure means its ability to pay dividends or satisfy financial obligations depends on the cash flows and distributions from its subsidiary, Cyabra Strategy Ltd.
• Future sales of common stock by the company or existing stockholders could dilute ownership and depress the market price.

Future Outlook

The company expects to continue incurring significant operating costs and losses in connection with product development and business expansion. It anticipates needing to raise additional capital to support operations and achieve profitability. The ability to secure sufficient funding is crucial for continued operations, and failure to do so may require reducing activities or ceasing operations. The company also has earnout share targets tied to future stock price performance at $15, $20, and $25 VWAP.

Management Comments

• Dan Brahmy, Co-Founder and Chief Executive Officer, stated: 'We are living in an era where the line between authenticity and manipulation is increasingly weaponized. As the first publicly traded company dedicated exclusively to fighting disinformation, we are uniquely positioned to give governments and enterprises the global platform they need to restore trust, expose inauthentic actors, and protect the narratives that shape our world. Closing this business combination with Trailblazer is an acceleration of our mission to defend digital reality.'

Industry Context

StockSavvy.ai notes that Cyabra operates in the critical and growing sector of fighting disinformation, a field gaining increasing importance for governments and enterprises globally. The company's public listing positions it to potentially capitalize on this demand, offering a platform to identify and mitigate manipulated online narratives. The market for digital trust and authenticity solutions is expanding due to geopolitical tensions and the proliferation of misinformation, suggesting a strong underlying demand for Cyabra's core offerings.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess Cyabra's performance against global industry benchmarks. Therefore, a direct comparison to industry standards is not possible based on the provided information.

Management Changes

Corporate Governance

Legal Proceedings

• The company acknowledges the risk of legal proceedings that may be instituted against it following the Closing, which could result in substantial costs and divert management's attention.

Related Party Transactions

• Alpha Capital Anstalt, an affiliate of Trailblazer Sponsor Group, LLC, provided Cyabra with multiple loans (2024 Convertible Notes, 2025 Note, 2025 Bridge Notes, 2025 Promissory Notes, December 2025 Promissory Note, January 2026 Promissory Note, February 2026 Promissory Note, March 2026 Promissory Note, March 2026 Second Promissory Note) totaling several millions of dollars, many of which were repaid or converted into preferred stock upon closing.
• The Sponsor Note (Second Amended and Restated Promissory Note from Trailblazer to the Sponsor) in the principal amount of $5.33 million converted into preferred shares of Holdings with a stated value of $15.99 million (Series B and Series C Preferred Stock).
• Loeb & Loeb LLP and Lowenstein Sandler LLP received convertible promissory notes for legal fees, which converted into 1,000,000 shares of Common Stock each upon closing, with a mechanism for premium payment if not fully satisfied by share sales.

Stakeholder Impact

• Shareholders: Existing shareholders of Cyabra and Trailblazer experienced a reclassification and conversion of their shares into Cyabra, Inc. common stock and preferred stock. New investors participated through the PIPE. Lock-up agreements restrict sales for 6-9 months, potentially impacting liquidity. Future dilution from earnout shares and equity incentive plans is possible.
• Employees: Key employees received fully vested restricted stock units (RSUs) and transaction bonuses, and new employment agreements were amended, providing incentives and stability. The 2026 Omnibus Equity Incentive Plan provides a framework for future equity awards.
• Customers: The business combination and public listing may enhance Cyabra's credibility and ability to invest in product development, potentially benefiting customers through improved services.
• Creditors: Various promissory notes were repaid or converted, altering the company's debt structure. The 'going concern' warning indicates potential risks for remaining creditors if additional funding is not secured.
• Regulatory Bodies: The company is now subject to SEC reporting obligations and Nasdaq listing requirements, increasing transparency and regulatory oversight.

Next Steps

• Management plans to continue commercialization of products and secure sufficient funding through additional equity securities sales.
• Earnout shares for Cyabra securityholders are contingent on achieving specific VWAP targets ($15, $20, $25) by December 31, 2026, December 31, 2027, and December 31, 2029, respectively.
• The company will need to file its 2026 Israeli Sub-Plan to the 2026 Plan with the Israel Tax Authority for certain RSU grants to become effective.

Key Dates

Recommendation

StockSavvy.ai recommends a 'hold' for Cyabra, Inc. following its Nasdaq listing. While the successful business combination and public market access are positive developments, the company's financial results for 2025 show a concerning increase in operating losses and flat ARR, coupled with a stated 'substantial doubt about its ability to continue as a going concern' without further capital. The reduction in net loss was primarily due to lower finance expenses, not improved operational efficiency. Investors should monitor the company's ability to secure additional funding, improve operational profitability, and demonstrate growth in its core business segments before considering further investment. The potential for significant dilution from future capital raises and earnout shares also warrants caution.

Keywords

Business Combination, SPAC, Nasdaq Listing, Preferred Stock, PIPE Investment, Convertible Notes, Disinformation, Financial Performance, Going Concern, Equity Incentive Plan, Risk Factors, CYAB